Meeting
2023 ASCO Quality Care Symposium
Chemo-Toxicity Calculator use in shared decision-making for chemotherapy treatment planning.
Authors
Alonso Victor Pacheco
Rocky Mountain Cancer Centers, Pueblo, CO
Alonso Victor Pacheco, Jean A Gress, Tamar Mcfarlane, Marcus Garcia, Lora Markley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Prospective Risk Assessment and Reduction
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 403)
DOI
10.1200/OP.2023.19.11_suppl.403
Abstract #
403
Poster Bd #
H13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Real-world experience of an in-house dihydropyrimidine dehydrogenase (DPYD) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital.
First Author: Jai Narendra Patel
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world assessment of capecitabine and oxaliplatin (CAPOX) tolerability in patients with localized colorectal cancer undergoing curative-intent therapy: A comprehensive single institution analysis.
First Author: Veronica Mears
Poster
2022 ASCO Annual Meeting
Modified CARG score using data from the electronic health record to predict chemotherapy toxicity in older adults.
First Author: Jasmine L Martin
Poster
2021 ASCO Annual Meeting
Pre-therapeutic dihydropyridimidine dehydrogenase (DPD) deficiency screening: Impact on fluoropyrimidine dose reduction at the second chemotherapy cycle and on early severe toxicity.
First Author: Côme De Metz